Lauren Riker
Corporate Officer/Principal chez PACIRA BIOSCIENCES, INC.
Fortune : 574 464 $ au 30/04/2024
Provenance du réseau au premier degré de Lauren Riker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 45 | |
Pacira Ltd.
 Pacira Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2007, Pacira Ltd. is a British pharmaceutical company that develops and manufactures pharmaceutical products. Part of Pacira Biosciences, Inc., the company is based in Bourne End, UK.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lauren Riker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| THE COOPER COMPANIES, INC. | Medical Specialties | Director of Finance/CFO Treasurer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
JPMorgan Investment Management, Inc.
 JPMorgan Investment Management, Inc. Investment ManagersFinance JPMorgan Investment Management, Inc. (JPMIM) is a global, SEC-registered investment advisor headquartered in New York City. The firm was founded in 2000 as the result of Chase Manhattan's purchase of Robert Fleming Holdings and the subsequent merger of Chase and JPMorgan. In January 2010, JPMorgan Investment Advisors merged into JP Morgan Investment Management. JPMIM is a subsidiary of JPMorgan Asset Management Holdings, Inc., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM). The firm primarily provides investment advisory services to both US and non-US institutional and retail clients. | Investment Managers | Analyst-Equity Analyst-Equity | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Director of Finance/CFO Compliance Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| CHIASMA, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| INDIVIOR PLC | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Consultant / Advisor | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Leeds | College/University | Undergraduate Degree | |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The company is based in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin Undergraduate Degree | |
| Siena College | College/University | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Undergraduate Degree | |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal President | |
Scleroderma Research Foundation
 Scleroderma Research Foundation BiotechnologyHealth Technology The Scleroderma Research Foundation is a non-profit organization that funds research for scleroderma, a potentially life-threatening illness. The non-profit company is based in San Francisco, CA. Established in 1987 by a patient-turned-activist, the foundation is the largest investor in scleroderma research. The foundation's goal is to find a cure for the disease by bringing together the best minds in science. The SRF has invested over $39 million dollars to date in scleroderma research, funding and facilitating research at top institutions such as Johns Hopkins University School of Medicine, Stanford University, and the University of California. | Biotechnology | Chairman Consultant / Advisor | |
Stack Pharmaceuticals, Inc.
 Stack Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Stack Pharmaceuticals, Inc. provides consulting services. The private company is based in Troy Hills, NJ. The company was founded by David M. Stack. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Vectorlogics, Inc.
 Vectorlogics, Inc. BiotechnologyHealth Technology Vectorlogics, Inc. develops and commercialized vaccines for virus based cancer therapies and viral liver diseases. The company was founded by David T. Curiel in 1998 and is headquartered in Birmingham, AL. | Biotechnology | Director/Board Member | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
Marwood Group LLC
 Marwood Group LLC Investment ManagersFinance Founded in 2000 by John T. Moore and Edward M. Kennedy, Jr., Marwood Group LLC is a healthcare advisory and financial services firm headquartered in New York City. The firm is a subsidiary of Marwood Group & Co. USA LLC | Investment Managers | President | |
Build NYC Resource Corp.
 Build NYC Resource Corp. Miscellaneous Commercial ServicesCommercial Services Build NYC Resource Corp. is an economic development agency that assists organizations and exempt facilities in accessing debt through tax-exempt bond financing for real estate capital investments. The non-profit company is based in New York, NY and has subsidiaries in the United States. | Miscellaneous Commercial Services | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MOELIS & COMPANY | Investment Banks/Brokers | Director/Board Member | |
Highgate LLC
 Highgate LLC Real Estate DevelopmentFinance Highgate LLC is a hospitality management and investing private company based in Birmingham, MI. Highgate LLC delivers market intelligence, scale, and technology to the hospitality industry. Highgate is known for its expertise in hotel management, investment, technology, and development, and has a diverse portfolio of hotels. The company was founded by Yvonne L. Greenstreet and Stephen R. Polk has been the CEO since 2013. | Real Estate Development | Chief Executive Officer | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Chief Executive Officer | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 45 |
| Royaume-Uni | 3 |
| France | 3 |
| Australie | 2 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 7 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 211 |
| Corporate Officer/Principal | 97 |
| Independent Dir/Board Member | 69 |
| President | 43 |
| Undergraduate Degree | 39 |
Relations les plus connectées
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Gary Pace | 32 |
| Fred Middleton | 30 |
| Laura Brege | 27 |
| David Stack | 27 |
| Scott Braunstein | 26 |
| Paul Hastings | 25 |
| Andreas Wicki | 21 |
| Gary Patou | 17 |
| Mark Kronenfeld | 16 |
| Dennis L. Winger | 15 |
| Yvonne Greenstreet | 15 |
| Taunia S. Markvicka | 14 |
| Mark Froimson | 13 |
| Abraham Ceesay | 13 |
- Bourse
- Insiders
- Lauren Riker
- Connexions Sociétés
